Decas Botanical Synergies LLC (Carver, MA) has obtained Korean Food and Drug Administration (KFDA) approval for a health claim of supporting urinary health for PACran, its cranberry powder. PACran is a clinically supported and proanthocyanidin-standardized cranberry powder. The supplier says that the approval is the first from KFDA for a health food product for urinary health.
Decas Botanical Synergies LLC (Carver, MA) has obtained Korean Food and Drug Administration (KFDA) approval for a health claim of supporting urinary health for PACran, its cranberry powder. PACran is a clinically supported and proanthocyanidin-standardized cranberry powder. The supplier says that the approval is the first from KFDA for a health food product for urinary health.
Senate Committee has released the text of 2024 Farm Bill, with changes to hemp regulations
November 19th 2024The U.S. Senate Committee on Agriculture, Nutrition, & Forestry has introduced the Rural Prosperity and Food Security Act, which will serve as the Senate’s draft for the 2024 Farm Bill.
NPA’s lawsuit against FDA on NMN stayed pending agency’s decision on citizen petition
November 6th 2024The court has granted a joint motion for stay filed by NPA and FDA, pending the agency's decision on the citizen petition asking FDA to reverse its stance on NMN's status as a dietary ingredient.